Lewy Body Disease: Clinical Trials

236 trials for Lewy Body Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

108 completed, 52 recruiting, 28 unknown, 14 not yet recruiting. 87 Not applicable, 37 Phase 2, 12 Phase 4, 10 Phase 1, 10 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable87Completed 42, Recruiting 15, Unknown 11, Not yet recruiting 6, Active not recruiting 5, Terminated 4, Enrolling by invitation 2, Withdrawn 2
Phase 237Completed 20, Recruiting 5, Terminated 4, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 412Completed 7, Enrolling by invitation 3, Recruiting 2
Phase 110Completed 4, Not yet recruiting 3, Recruiting 2, Unknown 1
Phase 310Completed 5, Recruiting 2, Unknown 2, Terminated 1
Early Phase 13Recruiting 2, Completed 1

Follow Lewy Body Disease: new trials by email Literature Review of Lewy Body Disease trials Research Report on Lewy Body Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Terazosin for Dementia With Lewy Bodies
Terazosin Hydrochloride, Placebo - Dementia With Lewy Bodies
Phase 1 / Phase 2Not yet recruitingQiang Zhang402027-10-012026-03-12
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Not yet recruitingBioSensics602027-01-152026-10-13
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia
VOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia, Standard of Care Educational Materials - Lewy Bodies Disease, Depression Disorder
Not applicableNot yet recruitingUniversity of Washington2202026-12-012026-06-09
Rhythmic Entrainment and Alertness in Lewy Body Dementia
Rhythmic Auditory Cueing - Dementia With Lewy Bodies (DLB), Lewy Body Dementia (LBD)
Not applicableNot yet recruitingJohns Hopkins University302026-11-302026-10-09
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
LBD Biomarker Education and Disclosure - Lewy Body Disease
Not yet recruitingStanford University402026-11-012026-06-15
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Mini-mental State Examination, Addenbrooke's Cognitive Examination, Speech Task - Picture Description - Dementia (Diagnosis), Alzheimer Dementia (AD)
Not yet recruitingZealand University Hospital4402026-11-012026-09-02
Visual Hallucinations in Lewy Body Diseases
Behavioral Tasks, MRI/MEG Scans - Lewy Body Disease, Lewy Body Dementia
RecruitingNYU Langone Health2342026-09-152026-09-30
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Not yet recruitingInternational Institute of Molecular and Cell Biology in Warsaw2002026-06-042026-05-28
Evaluating How Red-light Therapy Applied to the Head Affects Symptoms, Daily Life, and Brain Activity in People With Dementia With Lewy Bodies
LUCIOLE CAP, LUCIOLE CAP (sham version) - Photobiomodulation, Dementia With Lewy Bodies
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France402026-06-012026-06-23
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Donanemab, Placebo - Cognitive Dysfunction, Lewy Body Disease
Phase 2RecruitingEli Lilly and Company3502026-05-202026-10-08
18F-mFBG Cardiac Uptake With Lewy Body Dementia
18F-MFBG - Parkinson Disease (PD), Lewy Body Dementia (LBD)
Phase 2RecruitingInnervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)202026-04-302026-07-01
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
Alzheimer Disease, Dementia With Lewy Bodies (DLB)
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau17992026-02-192026-02-23
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
UHR PET/CT scan of the brain with ¹⁸F-FDG, UHR PET/CT scan of the brain with ¹⁸F-PE2I, UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1 - Alzheimer Dementia (AD), ALS - Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven3002026-02-132026-04-03
Social-cognitive Functioning: Validation of a New Neuropsychological Test
REALSOCOG, BCS, Hetero-questionnaires - Alzheimer's Disease (AD), Lewy Body Dementia (LBD)
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris1202026-02-042026-03-13
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Major Depressive Disorder (MDD), Schizophenia Disorder
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau13102026-02-012026-04-24
Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies
Biological : blood sampling, nasopharyngeal swab, Procedure : Lumbar puncture - Dementia With Lewy Bodies (DLB), Alzheimer's Disease (AD)
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France2862026-01-012025-09-10
Biofluid Research on Age-Related or Inherited Neurodegeneration
Frontotemporal Degeneration (FTD), ALS (Amyotrophic Lateral Sclerosis)
RecruitingUniversity of Pennsylvania10002025-12-122026-09-01
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims - Dementia With Lewy Bodies, Parkinson Disease Dementia
Phase 4RecruitingVirginia Commonwealth University1202025-12-082026-03-06
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
We did not apply any interventions; only observational research was conducted. - Multiple System Atrophy, Dementia With Lewy Bodies (DLB)
RecruitingSecond Affiliated Hospital of Soochow University5002025-11-122026-09-08
Non-invasive Diagnosis of Parkinson's Disease
Parkinsons Disease (PD)
Not yet recruitingBlekinge Institute of Technology602025-10-162025-10-01

Showing 20 of 236. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (108)  ·  Dementia (79)  ·  Parkinson Disease (69)  ·  Dementia, Vascular (54)  ·  Cognitive Dysfunction (49)  ·  Frontotemporal Dementia (38)  ·  Multiple System Atrophy (32)  ·  Supranuclear Palsy, Progressive (27)  ·  Mixed Dementias (24)  ·  Corticobasal Degeneration (19)  ·  Neurodegenerative Diseases (16)  ·  Amyotrophic Lateral Sclerosis (15)  ·  REM Sleep Behavior Disorder (14)  ·  Parkinsonian Disorders (12)

Broader conditions

Basal Ganglia Diseases (236)  ·  Central Nervous System Diseases (236)  ·  Mental Disorders (235)  ·  Brain Diseases (234)  ·  Nervous System Diseases (233)  ·  Neurocognitive Disorders (232)  ·  Movement Disorders (230)  ·  Synucleinopathies (230)  ·  Parkinsonian Disorders (224)  ·  Neurodegenerative Diseases (220)  ·  Dementia (157)  ·  Tauopathies (119)  ·  Pathological Conditions, Signs and Symptoms (64)  ·  Cardiovascular Diseases (62)  ·  Vascular Diseases (62)

Interventions

Donepezil (9)  ·  Transcranial Direct Current Stimulation (5)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (3)  ·  3-benzenesulfonyl-8-piperazin-1-ylquinoline (3)  ·  Electroencephalography (3)  ·  Magnetic Resonance Imaging (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Memantine (3)  ·  Neuropsychological Tests (3)  ·  ioflupane (3)  ·  nelotanserin (3)  ·  Algorithms (2)  ·  Ambroxol (2)  ·  Blood Specimen Collection (2)  ·  Galantamine (2)

Sponsors

Mayo Clinic (8)  ·  University Hospital, Strasbourg, France (7)  ·  Axovant Sciences Ltd. (6)  ·  Skane University Hospital (6)  ·  Eisai Co., Ltd. (5)  ·  Georgetown University (5)  ·  University College, London (5)  ·  University of Pennsylvania (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  NYU Langone Health (4)  ·  University of California, San Francisco (4)  ·  University of Washington (4)  ·  Danish Dementia Research Centre (3)  ·  EIP Pharma Inc (3)  ·  Eisai Inc. (3)

Countries

United States (108)  ·  France (28)  ·  Canada (14)  ·  United Kingdom (14)  ·  Italy (12)  ·  Spain (10)  ·  Sweden (9)  ·  China (8)  ·  Japan (8)  ·  Denmark (7)  ·  Germany (7)  ·  Belgium (6)  ·  Norway (6)  ·  Netherlands (5)  ·  South Korea (5)

Top investigators

Ilise Lombardo, MD (6)  ·  Erik Stomrud, MD, PhD (3)  ·  Fernando L Pagan, MD (3)  ·  Aimee Spector, PhD, DClinPsych (2)  ·  Bradley Boeve, MD (2)  ·  Horacio C Kaufmann, MD (2)  ·  Jeffrey Weiss, MD (2)  ·  Jori E Fleisher, MD MSCE (2)  ·  Julie Fields, PhD, LP (2)  ·  Katherine L Possin, PhD (2)  ·  Masaki Nakagawa (2)  ·  Steven Levy, MD (2)  ·  Adrian Ivanoiu, MD (1)  ·  Aimee Spector, PhD, DClinPsy (1)

Results publications

PMID 31566651, PMID 38706271, PMID 12021425, PMID 1202204, PMID 12671209, PMID 14676468, PMID 19500421, PMID 20729148, PMID 20944075, PMID 21878600, PMID 21908805, PMID 23527646, PMID 23666528, PMID 23785466, PMID 23911592, PMID 23930667, PMID 24969152, PMID 24993764, PMID 25044107, PMID 25155658, PMID 25162367, PMID 25411441, PMID 25635231, PMID 25713599, PMID 25713600, PMID 26120319, PMID 26354982, PMID 26756745, PMID 26836192, PMID 26856756, PMID 26878815, PMID 27042676, PMID 27146416, PMID 27164711, PMID 27241045, PMID 27357347, PMID 27362763, PMID 27393566, PMID 27469360, PMID 27579672, PMID 27694257, PMID 27709757, PMID 27765859, PMID 27900460, PMID 28061383, PMID 28179466, PMID 28271072, PMID 28323819, PMID 28689566, PMID 28800895

NIH funding

2017 (3), 2023 (2), P01AG066597 (2), P30AG064200 (2), R01AG056715 (2), R44AG065088 (2), 1UF1AG094587-01 (1), 2005 (1), I01CX000736 (1), K23AG073525 (1), K23AG073575 (1), K76AG060005 (1), P30AG072979 (1), P50AG008702 (1), P50AG016574 (1)